Biological Activities of Natural Products, Antipsychotics, and Novel Derivatives - Volume II
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Biochemistry, Biophysics and Computational Biology".
Deadline for manuscript submissions: closed (28 October 2022) | Viewed by 9278
Special Issue Editors
Interests: anticancer activity; cellular assays; bee products; antioxidant activity; phenothiazine derivatives
Special Issues, Collections and Topics in MDPI journals
Interests: electronic cigarettes; addiction; public health; toxycology
Special Issues, Collections and Topics in MDPI journals
Interests: natural bioactive compounds; polyphenols; chemoprevention; cell cycle; ovarian cancer biology; apoptosis; cytopathology; SARS-CoV-2 research
Special Issue Information
Dear Colleagues,
In our special issue we want to focus on anti-bacteria, anti-cancer, anti-fungal, anti-viral, and other biological activities of natural compound, antipsychotic drugs and their novel derivatives. All of the activities represents major problem of human health. The viral infections still represents major problem - up to date, antiviral drugs are used only for treating less than 10 viral infections (still no effective enough drugs against Zika, Ebola, and severe acute respiratory syndrome (SARS) virus). WHO confirmed 339,000 and 13,600–20,400, cases of deaths globally caused respectively by hepatitis C virus, and Japanese encephalitis virus. In case of COVID-19 5.374,744 cases of deaths up till now.
Next problem is increasing drug-resistance in microbial infections treatment. In 2019 WHO published a report to avert a potentially disastrous drug-resistance crisis – they predict about 10 million deaths each year by 2050 caused by drug-resistant diseases, while by 2030, antimicrobial resistance could force up to 24 million people into extreme poverty.
Another problem is global increase of deaths caused by different cardiovascular diseases indicated by the WHO and Eurostat statistics data for 2016, as well as the European Heart Network data for 2017. Noteworthy, in some cases, the global death percentage is higher than the number of deaths caused by malignant neoplasm cancer (26.0%).
Finally, due to the WHO cancer is a leading cause of death worldwide (in 2020 caused about 10 million deaths worldwide). The most common in 2020 were: breast, lung, colon & rectum, prostate, skin, and stomach cancers.
Thus, to find new and more effective methods of treating above mentioned diseases drug repurposing/repositioning or natural products can be used. For example, phenothiazine derivatives can be taken into consideration for repurposing in the bacterial and viral infections as well as cancer. On the other hand, natural products such as propolis, honey, pollen, royal jelly, and wax possess anti-inflammatory, anti-bacterial, anti-fungal, anticancer, neuroprotective, cardioprotective, and chemopreventive activity.
Dr. Michał Otręba
Dr. Leon Kosmider
Dr. Anna Kleczka
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- in vitro assays using human and/or animal cancer and normal cell lines (viability, cell death: apoptosis, necrosis, necroptosis, autophagy
- cellular migration & invasion
- cell cycle
- protein level
- enzymes activity
- proteins expression
- genes expression
- melanogenesis, antioxidant activity, and other)
- in vivo assays
- anticancer, antifungal, antibacterial, antiviral, and other biological activities
- cardiovascular, brain, viral, fungal, bacterial and other human diseases treatment
- antipsychotics and their new derivatives
- natural products biological and protective activities
- inhibition of bacterial growth (MIC, MBC)
- drug-resistance / Multidrug resistance (MDR)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.